Ocuphire Announces APX3330 and Nyxol® Data Presentations at ASCRS 2023 and Eyecelerator
FARMINGTON HILLS, Mich., May 02, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused...
Diagnostics
Qualigen Therapeutics’ Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Abstracts Feature Preclinical Data in (1) Pancreatic Cancer and (2) Luminal B Breast Cancer CARLSBAD, Calif., May 02, 2023 (GLOBE...
Predicine to Introduce PredicineALERT™ MRD Assay and Present Two ctDNA Studies in Genitourinary Cancers at AUA 2023 Annual Meeting
HAYWARD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, announced today that it will present...
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
Enabling Rapid and Reliable Diagnosis and Research of Rare Genetic Diseases Around the World CENTOGENE’s FilterTool aims to fuel rapid,...
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents...
Nexstim Plc’s New Shares Have Been Registered in Trade Register
Company Announcement, Helsinki, 25 April 2023 at 3 PM (EEST) Nexstim Plc’s New Shares Have Been Registered in Trade Register...
Mary Grace Rutland Joins PetVivo Holdings, Inc. as the Mid-Atlantic Business Development Manager
PetVivo Holdings, Inc. Mary Grace Rutland - New Business Development Manager for the Mid-Atlantic Region of the United StatesMINNEAPOLIS, MN,...
HTG Provides Update on Drug Discovery Partnering Initiative
TUCSON, Ariz., April 25, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools...
binx health and Mark Cuban Cost Plus Drug Company Team Up to Make Healthcare More Accessible and Affordable
Companies join forces to offer at-home access to affordable testing and prescription medications for millions of AmericansBOSTON, April 24, 2023...
Qualigen Therapeutics, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing
CARLSBAD, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life...
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
Meeting to Showcase EDAP’s Focal One® Robotic High Intensity Focused Ultrasound (HIFU) Platform for the Management of Prostate Cancer...
Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth
DUBLIN, Ireland, April 20, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer...
Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event
NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) -- Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced...
Microbix Presenting at the 2023 Bloom Burton Conference
MISSISSAUGA, Ontario, April 20, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator,...
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023
Failure to tender shares could result in the termination of the proposed merger between Chembio and BiosynexMEDFORD, N.Y., April 19,...
Publication Validates geneType Prostate Cancer Risk Test
MELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader...
New Published Real-World Evidence Shows KidneyIntelX™ Utility
Real-World Utility Data Demonstrates KidneyIntelX Optimizes Clinical Management in Early-Stage Chronic Kidney Disease Across Multiple Physician Specialties KidneyIntelX individualizes clinical...
Agios Appoints Jeffrey Capello to Board of Directors
– Board Member Paul Clancy Will Step Down at the End of His Term – CAMBRIDGE, Mass., April 19, 2023...
Plus Therapeutics Completes Enrollment of the Original Three Patients Required for Cohort 8 of ReSPECT-GBM Phase 1/2a Trial
Presentation of data from ReSPECT-GBM Phase 1/2a and Phase 2b trials expected second half of 2023AUSTIN, Texas, April 19, 2023...
Philips at HIMSS 2023: Enterprise Informatics central to solving productivity, staff and patient experience challenges
Unlocking enterprise-wide, actionable insights can help to improve outcomes April 17, 2023 Amsterdam, the Netherlands and Chicago, USA – Royal...